Evidence map›Paper›PMID 34141437›Full record

ArticleNew microbes and new infections2021

Performance of Wayne assay for detection of pyrazinamide resistance in

M J Nasiri, F Fardsanei, M Arshadi, B Deihim, Farima Khalili, M Dadashi, M Goudarzi, M Mirsaeidi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Enhancing diagnostic efficiency of pyrazinamide resistance inCurrent research in microbial sciences · 2025
    Article
  2. A simplified pyrazinamidase test forJournal of clinical microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

M J NasiriDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
F FardsaneiDivision of Microbiology, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
M ArshadiInfectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
B DeihimDepartment of Bacteriology and Virology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
Farima KhaliliDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
M DadashiDepartment of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
M GoudarziDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
M MirsaeidiDepartment of Pulmonary and Critical Care, University of Miami Miller School of Medicine, Miami, FL, USA.
Shahid Beheshti University of Medical Sciences · IRAhvaz Jundishapur University of Medical Sciences · IRAlborz University of Medical SciencesDezful University of Medical Sciences · IRTehran University of Medical Sciences · IRUniversity of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional culture-based drug susceptibility testing (DST) of

Indexed as

Pyrazinamideresistancesystematic reviewtuberculosisWayne assay

Identifiers

PMID34141437
PMCPMC8184659
OpenAlexW3157278987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.